Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea
· Delayed Price · Currency is KRW 13,730
-720 (-4.98%)
Mar 9, 2026, 3:30 PM KST
KRX:271980 Revenue
Jeil Pharmaceutical Co.,Ltd had revenue of 134.76B KRW in the quarter ending September 30, 2025, a decrease of -22.72%. This brings the company's revenue in the last twelve months to 621.98B, down -10.85% year-over-year. In the year 2024, Jeil Pharmaceutical Co.,Ltd had annual revenue of 704.54B, down -3.01%.
Revenue (ttm)
621.98B
Revenue Growth
-10.85%
P/S Ratio
0.32
Revenue / Employee
656.79M
Employees
947
Market Cap
200.07B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HLB Pharmaceutical | 36.10B |
| JW Lifescience | 248.30B |
| Samjin Pharmaceuticals | 274.03B |
| Samil Pharmaceutical Co.,Ltd | 215.04B |
| AptaBio Therapeutics | 3.44B |
| Daewon Pharmaceutical | 590.70B |
| REYON Pharmaceutical | 149.34B |
| Chong Kun Dang Holdings | 950.10B |